Andres Pichon-Riviere

Summary

Country: Argentina

Publications

  1. ncbi Early awareness and alert activities in Latin America: current situation in four countries
    Andres Pichon-Riviere
    Institute for Clinical Effectiveness and Health Policy, Argentina
    Int J Technol Assess Health Care 28:315-20. 2012
  2. ncbi Health technology assessment for resource allocation decisions: are key principles relevant for Latin America?
    Andres Pichon-Riviere
    Economic Evaluations Department, Institute for Clinical Effectiveness and Health Policy IECS and School of Public Health, University of Buenos Aires, Buenos Aires, Argentina
    Int J Technol Assess Health Care 26:421-7. 2010
  3. ncbi Transferability of health technology assessment reports in Latin America: an exploratory survey of researchers and decision makers
    Andres Pichon-Riviere
    Institute for Clinical Effectiveness and Health Policy IECS and University of Buenos Aires, Argentina
    Int J Technol Assess Health Care 28:180-6. 2012
  4. ncbi Development and validation of a microsimulation economic model to evaluate the disease burden associated with smoking and the cost-effectiveness of tobacco control interventions in Latin America
    Andres Pichon-Riviere
    Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina
    Value Health 14:S51-9. 2011
  5. ncbi Estimation of the burden of cardiovascular disease attributable to modifiable risk factors and cost-effectiveness analysis of preventative interventions to reduce this burden in Argentina
    Adolfo Rubinstein
    Institute for Clinical Effectiveness and Health Policy IECS, Buenos Aires, Argentina
    BMC Public Health 10:627. 2010
  6. ncbi [Budgetary impact analysis in health: update with a model using a generic approach]
    Osvaldo Ulises Garay
    Instituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina
    Rev Peru Med Exp Salud Publica 28:540-7. 2011
  7. ncbi Economic evaluation guidelines in Latin America: a current snapshot
    Federico Augustovski
    Instituto de Efectividad Clínica y Sanitaria IECS, Institute for Clinical Effectiveness and Health Policy, Buenos Aires, C1056ABH, Argentina
    Expert Rev Pharmacoecon Outcomes Res 10:525-37. 2010
  8. ncbi [Estimate of the cardiovascular disease burden attributable to modifiable risk factors in Argentina]
    Adolfo Rubinstein
    Instituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina
    Rev Panam Salud Publica 27:237-45. 2010

Detail Information

Publications8

  1. ncbi Early awareness and alert activities in Latin America: current situation in four countries
    Andres Pichon-Riviere
    Institute for Clinical Effectiveness and Health Policy, Argentina
    Int J Technol Assess Health Care 28:315-20. 2012
    ..The aim of this study was to briefly describe the current state of early awareness and alert (EAA) activities and systems in four Latin-American countries (Argentina, Brazil, Colombia, and Mexico)...
  2. ncbi Health technology assessment for resource allocation decisions: are key principles relevant for Latin America?
    Andres Pichon-Riviere
    Economic Evaluations Department, Institute for Clinical Effectiveness and Health Policy IECS and School of Public Health, University of Buenos Aires, Buenos Aires, Argentina
    Int J Technol Assess Health Care 26:421-7. 2010
    ..The objective of this research is to explore whether these KPs are relevant and useful in Latin America (LA), and to what extent they are being applied...
  3. ncbi Transferability of health technology assessment reports in Latin America: an exploratory survey of researchers and decision makers
    Andres Pichon-Riviere
    Institute for Clinical Effectiveness and Health Policy IECS and University of Buenos Aires, Argentina
    Int J Technol Assess Health Care 28:180-6. 2012
    ..HTA agencies, especially in developing countries, are under resourced and unable to conduct the desired amount of assessments. Adapting HTA reports (HTAs) from other jurisdictions is an alternative for saving resources...
  4. ncbi Development and validation of a microsimulation economic model to evaluate the disease burden associated with smoking and the cost-effectiveness of tobacco control interventions in Latin America
    Andres Pichon-Riviere
    Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina
    Value Health 14:S51-9. 2011
    ..To describe the development and validation of a health economic model (HEM) to address the tobacco disease burden and the cost-effectiveness of smoking cessation interventions (SCI) in seven Latin American countries...
  5. ncbi Estimation of the burden of cardiovascular disease attributable to modifiable risk factors and cost-effectiveness analysis of preventative interventions to reduce this burden in Argentina
    Adolfo Rubinstein
    Institute for Clinical Effectiveness and Health Policy IECS, Buenos Aires, Argentina
    BMC Public Health 10:627. 2010
    ..6% of potential years of life lost (PYLL). The aim of the study was to estimate the burden of acute coronary heart disease (CHD) and stroke and the cost-effectiveness of preventative population-based and clinical interventions...
  6. ncbi [Budgetary impact analysis in health: update with a model using a generic approach]
    Osvaldo Ulises Garay
    Instituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina
    Rev Peru Med Exp Salud Publica 28:540-7. 2011
    ..Its design explicitly adapts to the user skills and gaps in information, thus seeking to promote the development of these tools in the management fields in our countries...
  7. ncbi Economic evaluation guidelines in Latin America: a current snapshot
    Federico Augustovski
    Instituto de Efectividad Clínica y Sanitaria IECS, Institute for Clinical Effectiveness and Health Policy, Buenos Aires, C1056ABH, Argentina
    Expert Rev Pharmacoecon Outcomes Res 10:525-37. 2010
    ..In the near future we will be able to see if these documents were successfully used and applied for transparent and evidence-based decision making...
  8. ncbi [Estimate of the cardiovascular disease burden attributable to modifiable risk factors in Argentina]
    Adolfo Rubinstein
    Instituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina
    Rev Panam Salud Publica 27:237-45. 2010
    ..Estimate the burden of disease, the proportion attributable to the principal modifiable cardiovascular risk factors, and the direct medical cost of hospitalization associated with coronary heart disease and stroke in Argentina...